Mechanism of Ceftriaxone-Associated Pseudolithiasis Formation
Ceftriaxone is excreted in its unchanged form through the liver and kidneys, with 33% to 67% (average 40%) excreted unchanged via the kidneys, and the remainder via the biliary system. Therefore, the concentration of ceftriaxone in bile and kidneys is very high. The anion formed after ceftriaxone dissociation has a strong affinity for calcium ions, easily forming insoluble ceftriaxone-calcium salt precipitates in the bile ducts, gallbladder, and renal collecting system, thereby forming stones. Moreover, the concentration of ceftriaxone in the gallbladder is 20 to 150 times that in the blood; when it exceeds saturation, gel-like masses can deposit inside the gallbladder. In populations prone to stone formation, cholesterol in the bile acid pool is in a state of high saturation. After high doses of ceftriaxone, the concentration of the drug in bile increases and combines with bile acids, causing an imbalance in the bile acid pool, which leads to cholesterol crystallization and cholesterol stone formation. Ceftriaxone can also increase calcium ion concentration by affecting bile acid secretion, resulting in more precipitates. After discontinuation of the drug, the concentration of ceftriaxone in bile decreases, the ceftriaxone salts gradually dissolve into the bile and are excreted into the intestine with bile, the bile acid pool in the gallbladder can also return to balance, re-dissolving cholesterol stones and causing the deposits in the gallbladder to gradually disappear.
—— Gao Chen; Zhou Ying. Ceftriaxone-Associated Pseudolithiasis. Journal of Adverse Drug Reactions. 2011, 13(4): 236-4